Axitinib, 250 mg

Axitinib is characterized by a well-defined molecular structure, identified as a quinazoline derivative. Its molecular formula is C16H14N4O3, with a molecular weight of 306.3 g/mol. This compound belongs to the class of kinase inhibitors, specifically targeting vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR). Axitinib is supplied in a pure form as 250 mg tablets. It is known for its potent anticancer activity, particularly against renal cell carcinoma. Additionally, it exhibits good oral bioavailability and stable pharmacokinetics.

• CAS Number: 319460-85-0